PanArmenian.Net
08 Nov 2019, 18:37 GMT+10
PanARMENIAN.Net - For the first time in the United States, the gene editing tool known as CRISPR has been employed to fight cancer, doctors reported, according to WebMD.
So far, CRISPR has only been tried in three patients, two with multiple myeloma and one with a sarcoma. All had tried standard treatments, to no avail. With CRISPR, doctors extracted immune system cells from each patient and altered those cells genetically to help them spot and battle cancer cells. Side effects were minimal, the Associated Press reported.
'It's the most complicated genetic, cellular engineering that's been attempted so far,' study leader Dr. Edward Stadtmauer, of the University of Pennsylvania in Philadelphia, told the AP. 'This is proof that we can safely do gene editing of these cells.'
Two to three months later, one patient's cancer has progressed and one is stable. The third patient was treated recently, so it is too soon to tell if it worked. Fifteen more patients will get the treatment, to test safety and efficacy, the wire service reported.
'It's very early, but I'm incredibly encouraged by this,' Dr. Aaron Gerds, a Cleveland Clinic cancer specialist, told the AP.
This study is not aimed at changing the DNA within a person's body. Instead, the doctors used CRISPR to remove, alter and give back to the patient cells that are super-powered to fight their cancer -- a kind of immunotherapy.
Chinese scientists reportedly have tried this for cancer patients, but this is the first such study outside that country. It's so novel that it took more than two years to get approval from U.S. government regulators to try it, according to the AP.
Preliminary findings were released by the American Society of Hematology, and more details will be presented at the society's annual meeting in December.
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationNEW YORK CITY, New York: With just weeks to spare before a potential government default, U.S. lawmakers passed a sweeping tax and spending...
PARIS, France: Fast-fashion giant Shein has been fined 40 million euros by France's antitrust authority over deceptive discount practices...
PALO ALTO/TEL AVIV: The battle for top AI talent has claimed another high-profile casualty—this time at Safe Superintelligence (SSI),...
FRANKLIN, Tennessee: Hundreds of thousands of Nissan and Infiniti vehicles are being recalled across the United States due to a potential...
REDMOND, Washington: Microsoft is the latest tech giant to announce significant job cuts, as the financial strain of building next-generation...
LONDON UK - U.S. stock markets were closed on Friday for Independence Day. Global Forex Markets Wrap Up Friday with Greeback Comeback...
(Photo credit: Ken Blaze-Imagn Images) Trey Sweeney and Riley Greene each belted homers in the 10th inning and Tarik Skubal threw...
(Photo credit: Eric Hartline-Imagn Images) Zack Wheeler threw a dazzling one-hitter with 12 strikeouts as the Philadelphia Phillies...
(Photo credit: Nick Turchiaro-Imagn Images) The Toronto Blue Jays placed second baseman Andres Gimenez on the 10-day injured list...
(Photo credit: Ken Blaze-Imagn Images) Cleveland Guardians outfielder Lane Thomas returned to the 10-day injured list on Sunday because...
(Photo credit: MICHAEL CLUBB/SOUTH BEND TRIBUNE / USA TODAY NETWORK via Imagn Images) Notre Dame offensive lineman Charles Jagusah,...
(Photo credit: Lon Horwedel-Imagn Images) Tigers left-hander Tarik Skubal's quest for a second straight American League Cy Young...